Isoxazolidines as RIPK1 inhibitors and use thereof | Patent Number 11897876

US 11897876 B2
Application Number17983883
Publication NumberUS 20230203027 A1
Pendency1 year, 3 months, 6 days
Filled DateNov 9, 2022
Priority DateNov 9, 2022
Publication DateJun 29, 2023
Expiration DateNov 8, 2042
Inventor/ApplicantsElisabeth Defossa
Kurt Ritter
Gernot Zech
Hauke Szillat
Elisabeth DEFOSSA
Uwe HEINELT
Hauke SZILLAT
Gernot ZECH
Maria Mendez-Perez
Nils Rackelmann
Hans MATTER
Hans Matter
Kurt RITTER
Uwe Heinelt
Maria MENDEZ-PEREZ
Nils RACKELMANN
ExaminesHABTE, KAHSAY
Art Unit1624
Technology Center1600
Assignments
Sanofi
Current
Sanofi
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.